Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease

Michael Yong, Yu Qi Wu, Joel Howlett, Jeromie Ballreich, Evan Walgama, Andrew Thamboo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease'. Together they form a unique fingerprint.

Medicine & Life Sciences